Sabby Management’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-29,799
Closed -$223K 51
2024
Q2
$223K Buy
+29,799
New +$223K 0.15% 10
2023
Q3
Sell
-18,699
Closed -$1.61M 90
2023
Q2
$1.61M Buy
18,699
+11,793
+171% +$1.02M 1.32% 3
2023
Q1
$438K Buy
+6,906
New +$438K 0.38% 21